emricasan potential drug invented idun drug acquired pfizer sold conatus pharmaceuticals conatus turn licensed emricasan novartis exclusive development substance acts pancaspase inhibitor antiapoptotic antiinflammatory developed treatment liver granted fast track designation fda treatment nonalcoholic steatohepatitis substance first pancaspase inhibitor advance broad clinical testing novel mechanism action led research using potential drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikiemricasan